PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35217794-0	2022	N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/beta-catenin pathway in nasopharyngeal carcinoma.	7-methylguanosine	0-18	catenin beta 1	Homo sapiens	92-104	
35217794-3	2022	Here we show that N7-methylguanosine (m7G) tRNA modification enzyme METTL1 and its partner WDR4 are significantly elevated in NPC and are associated with poor prognosis.	7-methylguanosine	18-36	methyltransferase 1, tRNA methylguanosine	Homo sapiens	68-74	
35217794-3	2022	Here we show that N7-methylguanosine (m7G) tRNA modification enzyme METTL1 and its partner WDR4 are significantly elevated in NPC and are associated with poor prognosis.	7-methylguanosine	18-36	WD repeat domain 4	Homo sapiens	91-95	
35217794-7	2022	METTL1 upregulated the WNT/beta-catenin signaling pathway and promoted NPC cell epithelial-mesenchymal transition (EMT) and chemoresistance to cisplatin and docetaxel in vitro and in vivo.	Cisplatin	143-152	methyltransferase 1, tRNA methylguanosine	Homo sapiens	0-6	
35217794-7	2022	METTL1 upregulated the WNT/beta-catenin signaling pathway and promoted NPC cell epithelial-mesenchymal transition (EMT) and chemoresistance to cisplatin and docetaxel in vitro and in vivo.	Cisplatin	143-152	catenin beta 1	Homo sapiens	27-39	
35217794-7	2022	METTL1 upregulated the WNT/beta-catenin signaling pathway and promoted NPC cell epithelial-mesenchymal transition (EMT) and chemoresistance to cisplatin and docetaxel in vitro and in vivo.	Docetaxel	157-166	methyltransferase 1, tRNA methylguanosine	Homo sapiens	0-6	
35217794-7	2022	METTL1 upregulated the WNT/beta-catenin signaling pathway and promoted NPC cell epithelial-mesenchymal transition (EMT) and chemoresistance to cisplatin and docetaxel in vitro and in vivo.	Docetaxel	157-166	catenin beta 1	Homo sapiens	27-39